Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Erbel, G. Heusch (2000)
Coronary microembolization.Journal of the American College of Cardiology, 36 1
C. Heeschen, C. Hamm, B. Goldmann, Ariane Deu, L. Langenbrink, H. White (1999)
Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofibanThe Lancet, 354
C. Heeschen, M. Brand, C. Hamm, M. Simoons (1999)
Angiographic findings in patients with refractory unstable angina according to troponin T status.Circulation, 100 14
CW Hamm (1999)
Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levelsN Engl J Med, 340
C. Hamm, C. Heeschen, B. Goldmann, A. Vahanian, J. Adgey, C. Miguel, W. Rutsch, J. Berger, J. Kootstra, M. Simoons (1999)
Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.The New England journal of medicine, 340 21
M. E., Agnus, hman, Aul, A. W., Rmstrong, Obert, C. H., Hristenson, Hristopher, G. B., Ranger, Ugo, K. A., Atus, Alen, W. S., Agner, Rank, H. E., Arrell, C. M., Aliff, Ric, T. J., Opol (2000)
CARDIAC TROPONIN T LEVELS FOR RISK STRATIFICATION IN ACUTE MYOCARDIAL ISCHEMIA
M. Davies, A. Thomas, P. Knapman, and, J. Hangartner (1986)
Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death.Circulation, 73 3
L. Newby, E. Ohman, R. Christenson, D. Moliterno, R. Harrington, H. White, P. Armstrong, F. Werf, M. Pfisterer, V. Hasselblad, R. Califf, E. Topol (2001)
Benefit of Glycoprotein IIb/IIIa Inhibition in Patients With Acute Coronary Syndromes and Troponin T–Positive Status: The PARAGON-B Troponin T SubstudyCirculation: Journal of the American Heart Association, 103
B Lindahl, P Venge, L. Wallentin (1997)
Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protectionJ Am Coll Cardiol, 29
D. Huntsberger (1961)
Elements of statistical inference
J. Januzzi, S. Hahn, C. Chae, R. Giugliano, K. Lewandrowski, P. Théroux, I. Jang (2000)
Effects of tirofiban plus heparin versus heparin alone on troponin I levels in patients with acute coronary syndromes.The American journal of cardiology, 86 7
XQ Zhao (1999)
Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarctionCirculation, 100
(2017)
UvA-DARE ( Digital Academic Repository ) Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina : the CAPTURE study
E. Antman, M. Cohen, P. Bernink, C. Mccabe, T. Horácek, G. Papuchis, B. Mautner, R. Corbalán, D. Radley, E. Braunwald (2000)
The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.JAMA, 284 7
E. Falk (1985)
Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.Circulation, 71 4
E. Ohman, P. Armstrong, R. Christenson, C. Granger, H. Katus, C. Hamm, M. O'hanesian, G. Wagner, N. Kleiman, F. Harrell, R. Califf, E. Topol (1996)
Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators.The New England journal of medicine, 335 18
(2000)
Association of intracoronary thrombus and troponin I levels in patients with unstable angina or non-Q-wave myocardial infarction in PRISMPLUS
B. Lindahl, P. Venge, L. Wallentin (1997)
Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group.Journal of the American College of Cardiology, 29 1
E. Antman, M. Tanasijevic, B. Thompson, M. Schactman, C. Mccabe, C. Cannon, G. Fischer, A. Fung, C. Thompson, D. Wybenga, E. Braunwald (1996)
Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.The New England journal of medicine, 335 18
X. Zhao, P. Théroux, S. Snapinn, F. Sax (1999)
Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and sCirculation, 100 15
Background: Elevations in serum troponins among patients with acute coronary syndromes have been shown to identify those patients who are at high risk for poor outcome and who accrue larger relative benefits from aggressive antiplatelet and antithrombotic therapies. We studied a group of patients from the PRISM-PLUS trial to explore whether simply using serum troponin I, a serum marker of cardiac injury, could predict benefit of GP IIb/IIIa receptor antagonism with tirofiban.
Journal of Thrombosis and Thrombolysis – Springer Journals
Published: Oct 3, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.